Cargando…
PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044446/ http://dx.doi.org/10.1186/1546-0096-11-S2-P153 |
_version_ | 1782319146411753472 |
---|---|
author | Minoia, F Davì, S Horne, A Consolaro, A Rosina, S Davidsone, Z De Cunto, C De Inocencio, J Eisenstein, E Espada, G Fishbach, M Frosch, M Gallizzi, R Gamir, ML Griffin, T Grom, A Hennon, T Horneff, G Huasong, Z Ruperto, N Martini, A Cron, RQ Ravelli, A |
author_facet | Minoia, F Davì, S Horne, A Consolaro, A Rosina, S Davidsone, Z De Cunto, C De Inocencio, J Eisenstein, E Espada, G Fishbach, M Frosch, M Gallizzi, R Gamir, ML Griffin, T Grom, A Hennon, T Horneff, G Huasong, Z Ruperto, N Martini, A Cron, RQ Ravelli, A |
author_sort | Minoia, F |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4044446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40444462014-06-19 PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey Minoia, F Davì, S Horne, A Consolaro, A Rosina, S Davidsone, Z De Cunto, C De Inocencio, J Eisenstein, E Espada, G Fishbach, M Frosch, M Gallizzi, R Gamir, ML Griffin, T Grom, A Hennon, T Horneff, G Huasong, Z Ruperto, N Martini, A Cron, RQ Ravelli, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044446/ http://dx.doi.org/10.1186/1546-0096-11-S2-P153 Text en Copyright © 2013 Minoia et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Minoia, F Davì, S Horne, A Consolaro, A Rosina, S Davidsone, Z De Cunto, C De Inocencio, J Eisenstein, E Espada, G Fishbach, M Frosch, M Gallizzi, R Gamir, ML Griffin, T Grom, A Hennon, T Horneff, G Huasong, Z Ruperto, N Martini, A Cron, RQ Ravelli, A PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title | PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title_full | PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title_fullStr | PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title_full_unstemmed | PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title_short | PReS-FINAL-2141: Clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
title_sort | pres-final-2141: clinical features, therapeutic interventions and outcome of 362 patients with macrophage activation syndrome enrolled in a multinational survey |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044446/ http://dx.doi.org/10.1186/1546-0096-11-S2-P153 |
work_keys_str_mv | AT minoiaf presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT davis presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT hornea presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT consolaroa presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT rosinas presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT davidsonez presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT decuntoc presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT deinocencioj presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT eisensteine presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT espadag presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT fishbachm presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT froschm presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT gallizzir presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT gamirml presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT griffint presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT groma presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT hennont presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT horneffg presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT huasongz presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT ruperton presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT martinia presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT cronrq presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey AT ravellia presfinal2141clinicalfeaturestherapeuticinterventionsandoutcomeof362patientswithmacrophageactivationsyndromeenrolledinamultinationalsurvey |